Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Revenue

Vivozon Pharmaceutical had revenue of 6.76B KRW in the quarter ending September 30, 2025, a decrease of -71.40%. This brings the company's revenue in the last twelve months to 66.40B, down -23.92% year-over-year. In the year 2024, Vivozon Pharmaceutical had annual revenue of 87.60B with 22.83% growth.

• Revenue (ttm): 66.40B
• Revenue Growth: -23.92%
• P/S Ratio: 3.41
• Revenue / Employee: 216.27M
• Employees: 307
• Market Cap: 226.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	87.60B	16.28B	22.83%
Dec 31, 2023	71.32B	19.75B	38.31%
Dec 31, 2022	51.56B	-6.00B	-10.42%
Dec 31, 2021	57.56B	13.97B	32.04%
Dec 31, 2020	43.59B	-1.36B	-3.03%